Mettler-Toledo International Inc. (NYSE:MTD) Insider Christian Magloth Sells 750 Shares of Stock

Mettler-Toledo International Inc. (NYSE:MTD) insider Christian Magloth sold 750 shares of Mettler-Toledo International stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $772.09, for a total value of $579,067.50. Following the completion of the transaction, the insider now owns 901 shares of the company’s stock, valued at approximately $695,653.09. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Shares of MTD opened at $763.20 on Friday. The stock has a 50-day simple moving average of $799.24 and a 200-day simple moving average of $731.20. The company has a debt-to-equity ratio of 2.94, a quick ratio of 1.11 and a current ratio of 1.47. The stock has a market capitalization of $18.51 billion, a PE ratio of 33.73, a PEG ratio of 2.33 and a beta of 1.39. Mettler-Toledo International Inc. has a 1 year low of $638.92 and a 1 year high of $873.51.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, February 6th. The medical instruments supplier reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.68 by $0.10. The business had revenue of $843.97 million during the quarter, compared to analysts’ expectations of $835.43 million. Mettler-Toledo International had a return on equity of 118.08% and a net margin of 18.65%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.85 EPS. Analysts predict that Mettler-Toledo International Inc. will post 24.99 EPS for the current year.

Several equities analysts have recently issued reports on MTD shares. Zacks Investment Research cut Mettler-Toledo International from a “hold” rating to a “sell” rating and set a $845.00 price objective for the company. in a research note on Friday, January 3rd. UBS Group upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and set a $786.00 price objective for the company in a research note on Friday, February 7th. Citigroup started coverage on Mettler-Toledo International in a research note on Monday, January 6th. They issued a “neutral” rating and a $800.00 price objective for the company. Wells Fargo & Co started coverage on Mettler-Toledo International in a research note on Tuesday, January 7th. They issued an “equal weight” rating and a $815.00 price objective for the company. Finally, ValuEngine upgraded Mettler-Toledo International from a “sell” rating to a “hold” rating in a research note on Thursday, November 14th. Two investment analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $770.86.

A number of hedge funds have recently bought and sold shares of MTD. Point72 Asset Management L.P. increased its position in Mettler-Toledo International by 312.5% during the fourth quarter. Point72 Asset Management L.P. now owns 3,300 shares of the medical instruments supplier’s stock worth $2,618,000 after buying an additional 2,500 shares during the period. AQR Capital Management LLC increased its holdings in shares of Mettler-Toledo International by 39.4% in the fourth quarter. AQR Capital Management LLC now owns 140,666 shares of the medical instruments supplier’s stock valued at $111,226,000 after purchasing an additional 39,735 shares during the period. First Republic Investment Management Inc. increased its holdings in shares of Mettler-Toledo International by 18.2% in the fourth quarter. First Republic Investment Management Inc. now owns 5,780 shares of the medical instruments supplier’s stock valued at $4,585,000 after purchasing an additional 890 shares during the period. UBS Asset Management Americas Inc. increased its holdings in shares of Mettler-Toledo International by 5.8% in the fourth quarter. UBS Asset Management Americas Inc. now owns 112,077 shares of the medical instruments supplier’s stock valued at $88,908,000 after purchasing an additional 6,153 shares during the period. Finally, Loomis Sayles & Co. L P increased its holdings in shares of Mettler-Toledo International by 43.5% in the fourth quarter. Loomis Sayles & Co. L P now owns 172,478 shares of the medical instruments supplier’s stock valued at $136,824,000 after purchasing an additional 52,295 shares during the period. Hedge funds and other institutional investors own 95.88% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

Further Reading: How do candlesticks reflect price movement?

Insider Buying and Selling by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.